<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>Stme — News on 6ix</title>
<link>https://6ix.com/company/stme</link>
<description>Latest news and press releases for Stme on 6ix.</description>
<language>en-us</language>
<lastBuildDate>Thu, 19 Mar 2026 13:15:00 GMT</lastBuildDate>
<generator>6ix RSS</generator>
<atom:link href="https://6ix.com/rss/company/stme" rel="self" type="application/rss+xml" />
<item>
<title>StimCell Energetics Engages Stonegate Capital Partners for Research Coverage and Institutional Investor Outreach</title>
<link>https://6ix.com/company/stme/news/stimcell-energetics-engages-stonegate-capital-partners-for-research-coverage-and-institutional-investor-outreach</link>
<guid isPermaLink="true">https://6ix.com/company/stme/news/stimcell-energetics-engages-stonegate-capital-partners-for-research-coverage-and-institutional-investor-outreach</guid>
<pubDate>Thu, 19 Mar 2026 13:15:00 GMT</pubDate>
<description>StimCell Energetics Engages Stonegate Capital Partners for Research Coverage and Institutional Investor Outreach.</description>
</item>
<item>
<title>StimCell Energetics Inc. Announces Study into eBalance(R) Device's Impact on Neuronal Mitochondrial Function</title>
<link>https://6ix.com/company/stme/news/stimcell-energetics-inc-announces-study-into-ebalancer-devices-impact-on-neuronal-mitochondrial-function</link>
<guid isPermaLink="true">https://6ix.com/company/stme/news/stimcell-energetics-inc-announces-study-into-ebalancer-devices-impact-on-neuronal-mitochondrial-function</guid>
<pubDate>Tue, 02 Dec 2025 14:15:00 GMT</pubDate>
<description>StimCell Energetics Inc. Announces Study into eBalance(R) Device's Impact on Neuronal Mitochondrial Function.</description>
</item>
<item>
<title>OTC Markets Group Welcomes New OTCQB Companies – October 27</title>
<link>https://6ix.com/company/stme/news/otc-markets-group-welcomes-new-otcqb-companies-october-27-1</link>
<guid isPermaLink="true">https://6ix.com/company/stme/news/otc-markets-group-welcomes-new-otcqb-companies-october-27-1</guid>
<pubDate>Mon, 27 Oct 2025 11:15:19 GMT</pubDate>
<description>OTC Markets Group Welcomes New OTCQB Companies – October 27.</description>
</item>
<item>
<title>StimCell Energetics Inc. Successfully Uplists to OTCQB Market</title>
<link>https://6ix.com/company/stme/news/stimcell-energetics-inc-successfully-uplists-to-otcqb-market</link>
<guid isPermaLink="true">https://6ix.com/company/stme/news/stimcell-energetics-inc-successfully-uplists-to-otcqb-market</guid>
<pubDate>Fri, 24 Oct 2025 19:00:00 GMT</pubDate>
<description>StimCell Energetics Inc. Successfully Uplists to OTCQB Market.</description>
</item>
<item>
<title>StimCell Energetics Provides Sneak Peek at eBalance Redesign Progress and Announces Shares for Debt Transaction and the Engagement of Independent Investor Relations Consultant</title>
<link>https://6ix.com/company/stme/news/stimcell-energetics-provides-sneak-peek-200000692</link>
<guid isPermaLink="true">https://6ix.com/company/stme/news/stimcell-energetics-provides-sneak-peek-200000692</guid>
<pubDate>Wed, 26 Mar 2025 20:00:00 GMT</pubDate>
<description>VANCOUVER, BRITISH COLUMBIA / ACCESS Newswire / March 26, 2025 / StimCell Energetics Inc. (OTC PINK:STME) ("StimCell" or the "Company"), a biotech pioneer targeting cellular energy to enhance wellness, anti-aging, and longevity, is pleased to provide ...</description>
</item>
<item>
<title>StimCell Energetics Partners With ADM Tronics to Redesign eBalance Microcurrent Device for Home Use</title>
<link>https://6ix.com/company/stme/news/stimcell-energetics-partners-adm-tronics-140000960</link>
<guid isPermaLink="true">https://6ix.com/company/stme/news/stimcell-energetics-partners-adm-tronics-140000960</guid>
<pubDate>Tue, 25 Feb 2025 14:00:00 GMT</pubDate>
<description>Innovative Redesign Brings Smaller, Cost-Effective Unit with Advanced Diagnostics to Consumers VANCOUVER, BRITISH COLUMBIA / ACCESS Newswire / February 25, 2025 / StimCell Energetics Inc. (OTC PINK:STME) ("StimCell" or the "Company"), a biotech pioneer ...</description>
</item>
<item>
<title>Cell MedX Corp: Letter to Shareholders from Mr. Dwayne Yaretz, CEO</title>
<link>https://6ix.com/company/stme/news/cell-medx-corp-letter-to-shareholders-from-mr-dwayne-yaretz-ceo</link>
<guid isPermaLink="true">https://6ix.com/company/stme/news/cell-medx-corp-letter-to-shareholders-from-mr-dwayne-yaretz-ceo</guid>
<pubDate>Mon, 27 Jun 2022 12:01:40 GMT</pubDate>
<description>Cell MedX Corp: Letter to Shareholders from Mr. Dwayne Yaretz, CEO.</description>
</item>
<item>
<title>Cell MedX Corp. Appoints Mr. Dwayne Yaretz as CEO and Director</title>
<link>https://6ix.com/company/stme/news/cell-medx-corp-appoints-mr-dwayne-yaretz-as-ceo-and-director</link>
<guid isPermaLink="true">https://6ix.com/company/stme/news/cell-medx-corp-appoints-mr-dwayne-yaretz-as-ceo-and-director</guid>
<pubDate>Wed, 27 Apr 2022 13:01:47 GMT</pubDate>
<description>Cell MedX Corp. Appoints Mr. Dwayne Yaretz as CEO and Director.</description>
</item>
<item>
<title>Cell MedX Corp. to Attend the 29th Annual Wellness Show 2022 Held in Vancouver, BC</title>
<link>https://6ix.com/company/stme/news/cell-medx-corp-to-attend-the-29th-annual-wellness-show-2022-held-in-vancouver-bc</link>
<guid isPermaLink="true">https://6ix.com/company/stme/news/cell-medx-corp-to-attend-the-29th-annual-wellness-show-2022-held-in-vancouver-bc</guid>
<pubDate>Thu, 24 Mar 2022 12:01:30 GMT</pubDate>
<description>Cell MedX Corp. to Attend the 29th Annual Wellness Show 2022 Held in Vancouver, BC.</description>
</item>
<item>
<title>FDA Commences Review of Cell MedX's Premarket Notification (510K) and Health Canada Renews Class II Medical Device Licenses for eBalance(R) Systems</title>
<link>https://6ix.com/company/stme/news/fda-commences-review-of-cell-medxs-premarket-notification-510k-and-health-canada-renews-class-ii-medical-device-licenses-for-ebalancer-systems</link>
<guid isPermaLink="true">https://6ix.com/company/stme/news/fda-commences-review-of-cell-medxs-premarket-notification-510k-and-health-canada-renews-class-ii-medical-device-licenses-for-ebalancer-systems</guid>
<pubDate>Mon, 15 Nov 2021 13:31:19 GMT</pubDate>
<description>FDA Commences Review of Cell MedX's Premarket Notification (510K) and Health Canada Renews Class II Medical Device Licenses for eBalance(R) Systems.</description>
</item>
<item>
<title>Cell MedX Corp. Files Premarket Notification (510K) with the US Food and Drug Administration and Receives Canadian Trademark</title>
<link>https://6ix.com/company/stme/news/cell-medx-corp-files-premarket-notification-510k-with-the-us-food-and-drug-administration-and-receives-canadian-trademark</link>
<guid isPermaLink="true">https://6ix.com/company/stme/news/cell-medx-corp-files-premarket-notification-510k-with-the-us-food-and-drug-administration-and-receives-canadian-trademark</guid>
<pubDate>Fri, 17 Sep 2021 13:01:25 GMT</pubDate>
<description>Cell MedX Corp. Files Premarket Notification (510K) with the US Food and Drug Administration and Receives Canadian Trademark.</description>
</item>
<item>
<title>Cell MedX Corp. Converts Debt to Shares, Closes Non-brokered Private Placement Financing, and Engages Investor Relations Consultants</title>
<link>https://6ix.com/company/stme/news/cell-medx-corp-converts-debt-to-shares-closes-non-brokered-private-placement-financing-and-engages-investor-relations-consultants</link>
<guid isPermaLink="true">https://6ix.com/company/stme/news/cell-medx-corp-converts-debt-to-shares-closes-non-brokered-private-placement-financing-and-engages-investor-relations-consultants</guid>
<pubDate>Wed, 26 May 2021 12:00:00 GMT</pubDate>
<description>Cell MedX Corp. Converts Debt to Shares, Closes Non-brokered Private Placement Financing, and Engages Investor Relations Consultants.</description>
</item>
<item>
<title>Cell MedX Corp.’s eBalance Pro System Receives Class II Medical Device License from Health Canada</title>
<link>https://6ix.com/company/stme/news/cell-medx-corps-ebalance-pro-system-receives-class-ii-medical-device-license-from-health-canada</link>
<guid isPermaLink="true">https://6ix.com/company/stme/news/cell-medx-corps-ebalance-pro-system-receives-class-ii-medical-device-license-from-health-canada</guid>
<pubDate>Tue, 01 Sep 2020 15:24:03 GMT</pubDate>
<description>Cell MedX Corp.’s eBalance Pro System Receives Class II Medical Device License from Health Canada.</description>
</item>
<item>
<title>Cell MedX Corp. (CMXC) Closes Non-Brokered Private Placement Financing</title>
<link>https://6ix.com/company/stme/news/cell-medx-corp-cmxc-closes-non-brokered-private-placement-financing</link>
<guid isPermaLink="true">https://6ix.com/company/stme/news/cell-medx-corp-cmxc-closes-non-brokered-private-placement-financing</guid>
<pubDate>Tue, 04 Aug 2020 17:51:51 GMT</pubDate>
<description>Cell MedX Corp. (CMXC) Closes Non-Brokered Private Placement Financing.</description>
</item>
<item>
<title>Cell MedX Corp. Files Two Applications for Class II Medical Device Licenses with Health Canada</title>
<link>https://6ix.com/company/stme/news/cell-medx-corp-files-two-applications-for-class-ii-medical-device-licenses-with-health-canada</link>
<guid isPermaLink="true">https://6ix.com/company/stme/news/cell-medx-corp-files-two-applications-for-class-ii-medical-device-licenses-with-health-canada</guid>
<pubDate>Tue, 07 Jul 2020 12:02:46 GMT</pubDate>
<description>Cell MedX Corp. Files Two Applications for Class II Medical Device Licenses with Health Canada.</description>
</item>
<item>
<title>Cell MedX Corp. Receives Quality Management System ISO 13485:2016 MDSAP Certificate</title>
<link>https://6ix.com/company/stme/news/cell-medx-corp-receives-quality-management-system-iso-134852016-mdsap-certificate</link>
<guid isPermaLink="true">https://6ix.com/company/stme/news/cell-medx-corp-receives-quality-management-system-iso-134852016-mdsap-certificate</guid>
<pubDate>Tue, 09 Jun 2020 12:00:00 GMT</pubDate>
<description>Cell MedX Corp. Receives Quality Management System ISO 13485:2016 MDSAP Certificate.</description>
</item>
<item>
<title>Cell MedX Corp. Receives Quality Management System ISO 13485:2016 Certificate for the eBalance® Device</title>
<link>https://6ix.com/company/stme/news/cell-medx-corp-receives-quality-management-system-iso-134852016-certificate-for-the-ebalancer-device</link>
<guid isPermaLink="true">https://6ix.com/company/stme/news/cell-medx-corp-receives-quality-management-system-iso-134852016-certificate-for-the-ebalancer-device</guid>
<pubDate>Tue, 07 Apr 2020 13:23:30 GMT</pubDate>
<description>Cell MedX Corp. Receives Quality Management System ISO 13485:2016 Certificate for the eBalance® Device.</description>
</item>
<item>
<title>Cell MedX Corp. Reacquires World Wide Exclusivity Rights for the eBalanceⓇ Device</title>
<link>https://6ix.com/company/stme/news/cell-medx-corp-reacquires-world-wide-exclusivity-rights-for-the-ebalance-device</link>
<guid isPermaLink="true">https://6ix.com/company/stme/news/cell-medx-corp-reacquires-world-wide-exclusivity-rights-for-the-ebalance-device</guid>
<pubDate>Thu, 30 Jan 2020 16:39:19 GMT</pubDate>
<description>Cell MedX Corp. Reacquires World Wide Exclusivity Rights for the eBalanceⓇ Device.</description>
</item>
<item>
<title>Cell MedX Corp. Engages Dr. Peter Eppinga as Lead Investigator in the eBalanceⓇ R&D Experience Study</title>
<link>https://6ix.com/company/stme/news/cell-medx-corp-engages-dr-peter-eppinga-as-lead-investigator-in-the-ebalance-randd-experience-study</link>
<guid isPermaLink="true">https://6ix.com/company/stme/news/cell-medx-corp-engages-dr-peter-eppinga-as-lead-investigator-in-the-ebalance-randd-experience-study</guid>
<pubDate>Thu, 12 Dec 2019 13:00:00 GMT</pubDate>
<description>Cell MedX Corp. Engages Dr. Peter Eppinga as Lead Investigator in the eBalanceⓇ R&D Experience Study.</description>
</item>
<item>
<title>Cell MedX Corp. Receives eBalance Trademark</title>
<link>https://6ix.com/company/stme/news/cell-medx-corp-receives-ebalance-trademark</link>
<guid isPermaLink="true">https://6ix.com/company/stme/news/cell-medx-corp-receives-ebalance-trademark</guid>
<pubDate>Thu, 17 Oct 2019 12:00:00 GMT</pubDate>
<description>Cell MedX Corp. Receives eBalance Trademark.</description>
</item>
</channel>
</rss>